XERS

Xeris Pharmaceuticals Stock Price

3.305
-0.175 (-5.03%)
Upgrade to Real-Time
Regular Market
3.305

Low
2.31

52 Week Range

High
7.94

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Xeris Pharmaceuticals Inc XERS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.175 -5.03% 3.305 11:04:38
Open Price Low Price High Price Close Price Prev Close
3.47 3.2943 3.4901 3.48
Bid Price Ask Price Spread News
3.30 3.31 0.01 - 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,886 1,187,161 $ 3.39 $ 4,022,944 1,865,554 2.31 - 7.94
Last Trade Time Type Quantity Stock Price Currency
11:05:00 400 $ 3.305 USD

Xeris Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 219.24M 66.33M 65.52M $ 20.44M $ - -2.23 -1.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -20.00k 2.90%

more financials information »

Xeris Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical XERS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.054.053.273.691,911,735-0.745-18.4%
1 Month4.214.293.273.861,663,894-0.905-21.5%
3 Months7.157.803.274.772,502,151-3.85-53.78%
6 Months5.347.943.275.062,250,756-2.04-38.11%
1 Year2.637.942.314.532,458,1640.67525.67%
3 Years15.7527.98261.425.081,013,129-12.45-79.02%
5 Years15.7527.98261.425.081,013,129-12.45-79.02%

Xeris Pharmaceuticals Description

Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations. Its pipeline products are Diazepam, Pramlintide-Insulin, Self-Administered Glucagon, and others.


Your Recent History
NASDAQ
XERS
Xeris Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.